202 related articles for article (PubMed ID: 1692930)
21. Demonstration of a high affinity component of glyceryl trinitrate induced vasodilatation in the bovine mesenteric artery.
Ahlner J; Axelsson KL; Ljusegren ME; Grundström N; Andersson RG
J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(6):445-56. PubMed ID: 2826557
[TBL] [Abstract][Full Text] [Related]
22. Glyceryl trinitrate-induced vasodilation is inhibited by ultraviolet irradiation despite enhanced nitric oxide generation: evidence for formation of a nitric oxide conjugate.
Hussain AS; Crispino NH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Pharmacol Exp Ther; 1999 May; 289(2):895-900. PubMed ID: 10215668
[TBL] [Abstract][Full Text] [Related]
23. YC-1 enhances the responsiveness of tolerant vascular smooth muscle to glyceryl trinitrate.
O'Reilly DA; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 2001 Jan; 79(1):43-8. PubMed ID: 11201500
[TBL] [Abstract][Full Text] [Related]
24. Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta.
Liu Z; Brien JF; Marks GS; McLaughlin BE; Nakatsu K
J Pharmacol Exp Ther; 1993 Mar; 264(3):1432-9. PubMed ID: 8450477
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.
Hashimoto S; Kobayashi A
Clin Pharmacokinet; 2003; 42(3):205-21. PubMed ID: 12603173
[TBL] [Abstract][Full Text] [Related]
26. Diverse relaxation responses of canine large and small conductive coronary arteries to glyceryl trinitrate and nitric oxide on the one hand and to 8-bromoguanosine 3':5' cyclic monophosphate on the other.
Kitagawa T; Ishibashi T; Imai S
Jpn J Pharmacol; 1998 Jan; 76(1):101-4. PubMed ID: 9517410
[TBL] [Abstract][Full Text] [Related]
27. Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10,000 x g supernatant: biotransformation and nitric oxide formation.
Marks GS; McLaughlin BE; Brown LB; Beaton DE; Booth BP; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1991 Jun; 69(6):889-92. PubMed ID: 1913335
[TBL] [Abstract][Full Text] [Related]
28. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
[TBL] [Abstract][Full Text] [Related]
29. Contribution of activation of K+ channels to glyceryl trinitrate-induced relaxation of rabbit aorta.
Ishibashi T; Kawada T; Kato K; Hamaguchi M; Imai S
Gen Pharmacol; 1995 May; 26(3):543-52. PubMed ID: 7540579
[TBL] [Abstract][Full Text] [Related]
30. Thiol agents separate nitric oxide formation from vasodilation induced by glyceryl trinitrate.
Kearney MF; Brien JF; Marks GS; Lei H; Nakatsu K
Drug Metab Dispos; 1998 Jun; 26(6):547-51. PubMed ID: 9616190
[TBL] [Abstract][Full Text] [Related]
31. Endothelin receptor antagonism does not prevent the development of in vivo glyceryl trinitrate tolerance in the rat.
Ratz JD; Fraser AB; Rees-Milton KJ; Adams MA; Bennett BM
J Pharmacol Exp Ther; 2000 Nov; 295(2):578-85. PubMed ID: 11046091
[TBL] [Abstract][Full Text] [Related]
32. Effects of glyceryl trinitrate on endothelium-dependent and -independent relaxation and cyclic GMP levels in rat aorta and human coronary artery.
Rapoport RM; Waldman SA; Ginsburg R; Molina CR; Murad F
J Cardiovasc Pharmacol; 1987 Jul; 10(1):82-9. PubMed ID: 2441158
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate: a novel mechanism to explain preferential venodilation of organic nitrates.
Kojda G; Patzner M; Hacker A; Noack E
Mol Pharmacol; 1998 Mar; 53(3):547-54. PubMed ID: 9495823
[TBL] [Abstract][Full Text] [Related]
34. Superoxide does not inhibit glyceryl trinitrate-rabbit aortic strip-mediated relaxation of rabbit Taenia coli. Evidence against a role for nitric oxide itself as the smooth muscle active drug metabolite?
Hussain AS; Brien JF; Marks GS; Nakatsu K
Drug Metab Dispos; 1996 Jul; 24(7):780-5. PubMed ID: 8818576
[TBL] [Abstract][Full Text] [Related]
35. Effects of sulfobromophthalein and ethacrynic acid on glyceryl trinitrate relaxation.
Lau DT; Benet LZ
Biochem Pharmacol; 1992 May; 43(10):2247-54. PubMed ID: 1599510
[TBL] [Abstract][Full Text] [Related]
36. Effect of in vitro organic nitrate tolerance on relaxation, cyclic GMP accumulation, and guanylate cyclase activation by glyceryl trinitrate and the enantiomers of isoidide dinitrate.
Bennett BM; Schröder H; Hayward LD; Waldman SA; Murad F
Circ Res; 1988 Oct; 63(4):693-701. PubMed ID: 2901920
[TBL] [Abstract][Full Text] [Related]
37. Studies on the biphasic relaxant curve of glyceryl trinitrate in rat aorta: role of GTN metabolites.
Malta E
Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):829-35. PubMed ID: 2515014
[TBL] [Abstract][Full Text] [Related]
38. Dissociation of increases in cyclic GMP from relaxation of arterial smooth muscle.
Braughler JM
Eur J Pharmacol; 1981 Feb; 69(4):503-5. PubMed ID: 6265232
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation of glyceryl trinitrate by rat brain homogenate.
Marks GS; McLaughlin BE; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1992 Jun; 70(6):935-7. PubMed ID: 1423038
[TBL] [Abstract][Full Text] [Related]
40. [Two types of relaxation responses mediated by cyclic GMP in cerebral arteries].
Kanamaru K; Waga S; Kojima T; Fujimoto K
No To Shinkei; 1989 Jun; 41(6):559-65. PubMed ID: 2553081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
